Bailey HH et al. |
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days. |
2004 |
Cancer Chemother. Pharmacol. |
pmid:15205914
|
Loutrari H et al. |
Perillyl alcohol is an angiogenesis inhibitor. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15210838
|
Gupta A and Myrdal PB |
Development of a perillyl alcohol topical cream formulation. |
2004 |
Int J Pharm |
pmid:14706249
|
Yuri T et al. |
Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo. |
2004 |
Breast Cancer Res. Treat. |
pmid:15026623
|
Chen Y and Hu D |
Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells. |
2004 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:15165112
|
Kennedy S et al. |
Effect of antiproliferative agents on vascular function in normal and in vitro balloon-injured porcine coronary arteries. |
2003 |
Eur. J. Pharmacol. |
pmid:14637181
|
Ahn KJ et al. |
Cytotoxicity of perillyl alcohol against cancer cells is potentiated by hyperthermia. |
2003 |
Int. J. Radiat. Oncol. Biol. Phys. |
pmid:14529788
|
Clark SS et al. |
Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion. |
2003 |
Clin. Cancer Res. |
pmid:14555523
|
Liu G et al. |
Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer. |
2003 |
Invest New Drugs |
pmid:14578686
|
Russell J and Ling CC |
Studies with cytotoxic agents suggest that apoptosis is not a major determinant of clonogenic death in neuroblastoma cells. |
2003 |
Eur. J. Cancer |
pmid:14522384
|
Holstein SA and Hohl RJ |
Monoterpene regulation of Ras and Ras-related protein expression. |
2003 |
J. Lipid Res. |
pmid:12671036
|
Rajesh D et al. |
Perillyl alcohol as a radio-/chemosensitizer in malignant glioma. |
2003 |
J. Biol. Chem. |
pmid:12805388
|
Liston BW et al. |
Perillyl alcohol as a chemopreventive agent in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. |
2003 |
Cancer Res. |
pmid:12750258
|
Azzoli CG et al. |
A phase I trial of perillyl alcohol in patients with advanced solid tumors. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12695855
|
Morgan-Meadows S et al. |
Phase I trial of perillyl alcohol administered four times daily continuously. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12904896
|
Rajesh D and Howard SP |
Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cells. |
2003 |
Prostate |
pmid:12886519
|
Elegbede JA et al. |
Perillyl alcohol and perillaldehyde induced cell cycle arrest and cell death in BroTo and A549 cells cultured in vitro. |
2003 |
Life Sci. |
pmid:14511768
|
Burke YD et al. |
Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. |
2002 Nov-Dec |
Anticancer Res. |
pmid:12530055
|
Murren JR et al. |
Phase I study of perillyl alcohol in patients with refractory malignancies. |
2002 Mar-Apr |
Cancer Biol. Ther. |
pmid:12170772
|
Miyazawa M et al. |
Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. |
2002 |
Drug Metab. Dispos. |
pmid:11950794
|